Filed in archive
Digestive Disorders
, FDA Approvals
, Treatment
by Gloria Gamat on January 15, 2008

Previously approved for use in the treatment of some forms of multiple sclerosis (MS) - Tysabri (natalizumab) - is now approved by the FDA for the treatment of moderate-to-severe Crohn's disease in patients with evidence of inflammation (not fully respondent or tolerant to conventional therapies).
Crohn's disease patients using the drug must be enrolled in a special restricted distribution program called the Crohn's Disease-Tysabri Outreach Unified Commitment to Health (CD TOUCH) Prescribing Program.
The approval is consistent with an agency advisory committee recommendation to approve Tysabri for use in Crohn's patients. Tysabri was approved by the FDA in June 2006 to treat relapsing forms of multiple sclerosis.
Of unknown cause, Chron's disease is a chronic, inflammatory bowel disease that affects both men and women; with no cure and suffered by more than 1 million people worldwide.
Manufactured by Biogen Idec (Cambridge, Massachusetts) and Elan (Dublin, Ireland), Tysabri carries a boxed warning for progressive multifocal leukoencephalopathy (PML) - an opportunistic viral infection affecting the brain which can lead to death or severe disability.
Find more details from the FDA News.
[Photo Credit: NY Times]
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/110518
Mr Wong
Vote for Tysabri (natalizumab): Approved by FDA For Moderate-to-Severe Crohn's Disease:
|
Rating: 6.00 out of 3 vote(s) cast.
|
Response from:
Connecting News, Commentaries and Blogs at NineReports.com
Profit at Biogen Rises 84% on 2 Drugs ...Blogged about at Tysabri (natalizumab): Approved by FDA For Moderate-to-Severe Crohn&1;s Disease - straightfromthedoc, BOSTON (Reuters) Biogen Idec said on Wednesday its fourth-quarter profit rose 84 perc...
Response from:
Trusted.MD Network
With no cure and still of unknown cause - Crohn's disease - is a chronic, inflammatory bowel disease that affects more than 1 million men and women worldwide.
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |









